Vanta reports four risk treatment strategies-mitigate, accept, transfer, and avoid-to effectively manage threats, enhancing ...

S. Korea's defense research agency launched a secure in-house generative artificial intelligence system to protect secrets ...

Trump’s plans for dismantling the Education Department are sparking concerns that the federal government will fall short in ...

INFRONEER Holdings Inc. ("INFRONEER HD"), in collaboration with Accenture (NYSE: ACN) and SAP Japan, today announced that it has built a new financial data and insights platform—the digital core of ...

Bilibili Inc. (“Bilibili” or the “Company”) (Nasdaq: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today provided an update on its two-year US$300 ...

Opus Genetics, Inc. (Nasdaq: IRD) (the "Company” or "Opus Genetics”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...

After 17 years with the Los Angeles Philharmonic, departing music and artistic director Gustavo Dudamel will play a final benefit concert for Venezuela at the Hollywood Bowl on Aug. 23.

Internal documents contradict statements from USDA leaders, who repeatedly said they did not anticipate relocations would ...

ATUM, a leading US-based contract research organization, selected to support stable clonal cell line generation to advance VERAXA’s lead BiTAC-TCE program toward IND/CTA-enabling activities ...

Locally-based Apptronik debuted its Apollo 2 humanoid robot to be used at the company's newly opened North Austin training ...

New federal caps sharply restrict graduate school student loans. Learn how the strict limits impact tuition, college costs ...

TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the initiation of a Phase 2 clinical trial evaluating BRIUMVI® (ublituximab-xiiy), in adults with treatment-resistant schizophrenia. The Phase 2 ...